DVC
ALNA

Deer VII & Co’s Allena Pharmaceuticals ALNA Stock Holding History

Deer VII & Co’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,263,365
Closed -$2.17M – 3
2020
Q1 		$2.17M Hold
2,263,365
– – 2.15% 2
2019
Q4 		$6.18M Hold
2,263,365
– – 6.01% 2
2019
Q3 		$8.92M Hold
2,263,365
– – 10.29% 3
2019
Q2 		$9.21M Hold
2,263,365
– – 8.07% 2
2019
Q1 		$15.9M Hold
2,263,365
– – 50.04% 1
2018
Q4 		$12.3M Hold
2,263,365
– – 34.37% 2
2018
Q3 		$24.3M Hold
2,263,365
– – 36.46% 2
2018
Q2 		$29.5M Hold
2,263,365
– – 35.22% 2
2018
Q1 		$22.4M Hold
2,263,365
– – 83.81% 1
2017
Q4 		$20.5M Buy
+2,263,365
New +$27.9M 82.81% 1

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Deer VII & Co's ALNA Position: Q2 2020 in Review

Deer VII & Co sold out of Allena Pharmaceuticals (ALNA) in Q2 2020, closing a stake of 2,263,365 shares — an estimated $2.17M sold.

Deer VII & Co first reported a position in ALNA in Q4 2017 and held it in 10 quarters. The position peaked at $29.5M in Q2 2018. 30 funds tracked by Wall St. Rank hold ALNA as of Q2 2020.

  • Deer VII & Co reported no remaining Allena Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Deer VII & Co sold 2,263,365 Allena Pharmaceuticals shares in Q2 2020, an estimated $2.17M.
  • Deer VII & Co first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 10 quarters.
  • Deer VII & Co's Allena Pharmaceuticals position peaked at $29.5M in Q2 2018.
  • 30 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q2 2020.

Based on Deer VII & Co's 13F filing for Q2 2020, filed 14 Aug 2020.